|
The Natural Connection
|
|
| Spring
has barely made it’s entrance in South Georgia, the promise of summer not far
behind, and already my patients are announcing their plans for summer gardens,
beach walks at sunset, grandkids on the knee at family reunions. But for those
who are among the 21 million Americans with osteoarthritis, these happy events
are often accompanied by stiff and gnarled fingers, painful hips, and swollen
knees. “Ole Arthur is paying me a visit,” they say. “You got anything for
that?” Conventional medical therapy often includes medications known as non-steroidal anti-inflammatory agents (NSAIDS), such as ibuprofen and naproxen. These medications are often poorly tolerated by many people, however, due to their side effects of stomach ulcers, kidney failure, and liver problems. The newer NSAIDS, like Celebrex and Vioxx, while less irritating to the lining of the stomach, certainly irritate the pocketbook with monthly costs of over $100. Many of my patients, like apparently millions of their fellow arthritis
sufferers are also asking questions about using glucosamine sulfate for their
symptoms. One billion capsules were sold in 1998 to Americans looking for “The
Arthritis Cure”. Ever since a
popular book was published three years ago by the same name, physicians have
been investigating whether there is any truth to the claims that glucosamine, a
natural substance derived from the shells of lobster, shrimp, and crabs, can
really do anything to alleviate the pain that plagues so many people with the
most common form of degenerative joint disease,
osteoarthritis. Glucosamine has been extensively studied in Europe and Asia for a number
of years, and studies in those countries have been promising. A review of nine
research trials published in 1998 concluded that glucosamine was apparently safe
and could offer moderate, short-term relief from the pain of osteoarthritis,
similar to NSAIDS. Some of these studies where of short duration, however, or
had small numbers of patients. So still American arthritis specialists were
skeptical. In November of 1999, preliminary results of a large Belgian trial were
presented at the American College of Rheumatology indicating that in a
three-year period, the supplement not only reduced pain symptoms, but also
slowed cartilage loss. I have personally seen electron micrographs of cartilage
cells of patients before and after glucosamine therapy that show the cells to be
healthier than in control patients. Many physicians feel that it is time for
conventional medicine to take another look at glucosamine. Due to the increasing data that seems to indicate that glucosamine is a
safe, effective, and low cost alternative to prescription medication for some
patients with mild arthritis, the National Institutes of Health (NIH) has
recently awarded the University of Utah School of Medicine a $6.6 million grant
to coordinate a clinical trial on 1,000 osteoarthritis patients. These patients
will take either glucosamine, chondroitan (another supplement of interest in
arthritis), a combination of both, or a placebo for four months. American
physicians and their patients may soon have an answer to the problem of “Ole
Arthur” after all. For the countless patients who do not want to wait until the answer is
in, or who are already taking some form of glucosamine, there are a few safety
tips to remember. The most effective dose is not known, but appears to be in the
range of 1500 mg daily. It is a slow acting supplement, and you may not see an
effect for several weeks. However, if you have not had a response or decrease in
pain in three months of therapy, you should probably stop the medication, or try
switching to another brand. Glucosamine can be used safely with NSAIDS, and many
people take both. The quality of the glucosamine preparations on the market today is very
variable. A company called Consumer Labs publishes reports of independent
product testing to help patients and their physicians decide which of the
countless formulas available are worth a try. Also, the sulfate form of the drug
is more extensively studied than the hydrochloride (HCl) form. The back of the
bottle will tell you which form is in your preparation. Glucosamine has not been tested in pregnant women, children, or the very
elderly. These groups should avoid the medication until more is known about the
drug. Diabetics, in particular, should be aware that glucosamine is thought to
increase insulin resistance, and in animal studies it has been shown to increase
blood glucose levels. All patients should let their doctors know if they are
trying glucosamine, and be sure to find out from your doctor if your aches and
pains are from osteoarthritis. Glucosamine is not believed to be useful in other
types of bone or joint disease. If you would like to receive more information on the NIH trial of glucosamine or on the Consumer Lab test program, please write to: The Natural Connection, c/o Dr. Pauline Bellecci, Southeast Internal Medicine, PO Box 777, Waycross, GA 31501 or visit www.swampdocs.com |
|
©2000-2003 Pauline M. Bellecci, MD
|